Stillerman Girgis hälso-sjukvård AB
ActiveKey figures
Key figures
2025Summary: Stillerman Girgis hälso-sjukvård AB
What kind of company is it?
Stillerman Girgis hälso-sjukvård AB (org. no. 559206-9461) is a limited company (AB). The company was registered in 2019 and has existed for 7 years. Registered seat: Järfälla. Industry according to Statistics Sweden: general primary medical practice activities (SNI 86211).
How is the company doing financially?
Net sales in financial year 2025 were 2 016 699 kr, up 109 % on the previous year (963 603 kr). From 2022 to 2025, net sales grew by an average of 264 % per year. This is the highest net sales among the reported years (2022–2025). Net profit for 2025 was 293 250 kr (14,5 % of net sales). The company was profitable in 3 of the 4 reported financial years. Employees in financial year 2025: 2. Net sales per employee were 1 008 350 kr. At the end of financial year 2025, total assets were 1 115 506 kr and equity 436 342 kr (equity ratio 39,1 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Sales revenue | 41 800 | 105 999 | 963 603 | 2 016 699 |
| Profit for the reporting year | 1 902 | −36 268 | 235 946 | 293 250 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 68 228 | 46 955 | 573 388 | 1 115 506 |
| Total liabilities | 24 814 | 39 809 | 330 296 | 679 164 |
| Total equity | 43 414 | 7 146 | 243 092 | 436 342 |
| Employees | — | 1 | 2 | 2 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.